EXCHANGE TRADED CONCEPTS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$570,266
-4.5%
6,6690.0%0.02%
-11.8%
Q3 2023$597,409
+132.5%
6,669
+72.9%
0.02%
+112.5%
Q2 2021$257,000
-34.4%
3,857
+9.2%
0.01%
-46.7%
Q1 2021$392,000
-16.9%
3,532
-11.2%
0.02%
-31.8%
Q4 2020$472,000
+42.6%
3,978
+4.7%
0.02%
+15.8%
Q3 2020$331,000
+26.3%
3,798
+29.8%
0.02%
-55.8%
Q2 2020$262,0002,9250.04%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders